Small-molecule PROTACs for EGFR are demonstrated to decline IDO1 as well as PD-L1 in non-small cell lung cancer (NSCLC) cell lines and tumor tissues [119]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.